Ovarian Cancer
New ovarian cancer study findings have been reported by J.M. Riedinger and co-researchers
Published in Cancer Weekly, July 15th, 2008
"CA 125 half-life and nadir concentration were compared to patient outcome. Some patients (n=38, 29.2%) presented a CA 125 bi-exponential decrease and its clinical implication was studied. Survival analyses for disease-free survival (DFS) and overall survival (OS) used univariate (Kaplan-Meier) and multivariate (Cox model). During a median follow-up time of 29 months (range 5-106 months), 111 patients (85%) relapsed and 94 (72%) died...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-07-15)
More Articles from Cancer Weekly
- UT Southwestern Medical Center
Urologists identify 7 biomarkers that may help pinpoint prostate cancer recurrence - Adenovirus
New adenovirus research has been reported by scientists at University of Oxford - Bayer HealthCare Pharmaceuticals Inc.
Journal of Clinical Oncology Publishes Leukine Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma - Breast Cancer
Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate With Outcomes in Breast Cancer - Cancer
Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma - Cancer Gene Therapy
New cancer gene therapy research from N.H. Zhang and colleagues discussed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
